285 related articles for article (PubMed ID: 25434353)
1. Epothilones: From discovery to clinical trials.
Forli S
Curr Top Med Chem; 2014; 14(20):2312-21. PubMed ID: 25434353
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Activity of Epothilone D.
Cheng H; Huang G
Curr Drug Targets; 2018; 19(15):1866-1870. PubMed ID: 30073925
[TBL] [Abstract][Full Text] [Related]
3. Synthesis & antitumor activity of epothilones B and D and their analogs.
Cheng H; Huang G
Future Med Chem; 2018 Jun; 10(12):1483-1496. PubMed ID: 29788770
[TBL] [Abstract][Full Text] [Related]
4. Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues.
Fumoleau P; Coudert B; Isambert N; Ferrant E
Ann Oncol; 2007 Jul; 18 Suppl 5():v9-15. PubMed ID: 17656562
[TBL] [Abstract][Full Text] [Related]
5. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
[TBL] [Abstract][Full Text] [Related]
6. Preclinical investigations with epothilones in breast cancer models.
Burris HA
Semin Oncol; 2008 Apr; 35(2 Suppl 2):S15-21; quiz S39. PubMed ID: 18410795
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents.
Fojo T; Menefee M
Ann Oncol; 2007 Jul; 18 Suppl 5():v3-8. PubMed ID: 17656560
[TBL] [Abstract][Full Text] [Related]
8. Diversity through semisynthesis: the chemistry and biological activity of semisynthetic epothilone derivatives.
Altmann KH; Gaugaz FZ; Schiess R
Mol Divers; 2011 May; 15(2):383-99. PubMed ID: 21197573
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of isotopically labeled epothilones.
Ganesh T; Brodie PJ; Banerjee A; Bane S; Kingston DG
J Labelled Comp Radiopharm; 2014 Feb; 57(2):78-81. PubMed ID: 24307484
[TBL] [Abstract][Full Text] [Related]
10. Epothilones as lead structures for new anticancer drugs--pharmacology, fermentation, and structure-activity-relationships.
Altmann KH; Memmert K
Prog Drug Res; 2008; 66():273, 275-334. PubMed ID: 18416309
[TBL] [Abstract][Full Text] [Related]
11. Development of other microtubule-stabilizer families: the epothilones and their derivatives.
Brogdon CF; Lee FY; Canetta RM
Anticancer Drugs; 2014 May; 25(5):599-609. PubMed ID: 24398663
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of epothilone B.
Cheng H; Huang H; Huang G
Eur J Med Chem; 2018 Sep; 157():925-934. PubMed ID: 30149324
[TBL] [Abstract][Full Text] [Related]
13. High-resolution X-ray structure of three microtubule-stabilizing agents in complex with tubulin provide a rationale for drug design.
Xiao Q; Xue T; Shuai W; Wu C; Zhang Z; Zhang T; Zeng S; Sun B; Wang Y
Biochem Biophys Res Commun; 2021 Jan; 534():330-336. PubMed ID: 33272565
[TBL] [Abstract][Full Text] [Related]
14. Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.
Trivedi M; Budihardjo I; Loureiro K; Reid TR; Ma JD
Future Oncol; 2008 Aug; 4(4):483-500. PubMed ID: 18684060
[TBL] [Abstract][Full Text] [Related]
15. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
16. Epothilones as Natural Compounds for Novel Anticancer Drugs Development.
Villegas C; González-ChavarrĂa I; Burgos V; Iturra-Beiza H; Ulrich H; Paz C
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047035
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of new functionalized epothilones for prodrug design and tumor targeting.
Dietrich SA; Riediker L; Gertsch J; Altmann KH
Chimia (Aarau); 2010; 64(3):136-9. PubMed ID: 21140905
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the study of tubulin inhibitors].
Shang H; Pan L; Yang S; Chen H; Cheng MS
Yao Xue Xue Bao; 2010 Sep; 45(9):1078-88. PubMed ID: 21351562
[TBL] [Abstract][Full Text] [Related]
19. CENP-E checks in microtubule-drug resistance.
Chanel-Vos C; Giannakakou P
Cell Cycle; 2010 Apr; 9(8):1456. PubMed ID: 20421712
[No Abstract] [Full Text] [Related]
20. Targeting the microtubules in breast cancer beyond taxanes: the epothilones.
Cortes J; Baselga J
Oncologist; 2007 Mar; 12(3):271-80. PubMed ID: 17405891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]